Here the focus is on how long each stage of a Depo-Provera lawsuit typically takes—from intake and filing through discovery, bellwether trials, and potential settlement—so you can set realistic expectations.

This page describes typical stages of a Depo-Provera meningioma case from first contact to resolution—not how long your case will take (that varies). For current court activity and filings, see Depo-Provera lawsuit updates. For state filing deadlines, see Depo-Provera statute of limitations by state.

From Consultation to Filing

Case review: You discuss your Depo-Provera use and meningioma diagnosis in a free, confidential evaluation. The firm determines whether you may qualify and explains next steps. No obligation.

Building your file: If you move forward, the firm gathers medical records, imaging, prescription history, and other evidence. This phase often takes a few weeks to a few months depending on providers and records.

Filing the lawsuit: Your attorney files a complaint in the appropriate court. Your case may stay individual or be coordinated with other Depo-Provera cases for pretrial proceedings (e.g., MDL). Filing typically happens within a few months of engagement, subject to your state’s deadline.

Discovery and Resolution

Discovery: Both sides exchange information and documents. In drug injury cases this can take many months. Expert opinions on causation and damages are often part of this stage.

The National Brain Tumor Society notes that meningiomas account for roughly one-third of all primary brain tumors in adults—context that helps readers understand why even a modest relative risk increase can affect many patients.

A 2024 *BMJ* study of French national health data reported that prolonged use of medroxyprogesterone acetate injectable contraception was associated with a 5.6-fold higher risk of intracranial meningioma requiring surgery among long-term users compared with non-users.

If you used Depo-Provera and were diagnosed with a brain tumor, you may have legal options.

Free, confidential Depo-Provera case review. Find out if you qualify.

Get a free Depo-Provera case review

According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.

Settlement or trial: Many pharmaceutical cases resolve by settlement. If the parties do not settle, your case could go to trial. Timing depends on court dockets, the number of cases, and litigation strategy. There are no guarantees.

According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.

Your role: Stay in touch with your attorney, respond to requests for information, and attend appointments or depositions as needed. Your lawyer will keep you updated on major steps.

According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.

For what to expect in terms of litigation news over time, see Depo-Provera lawsuit updates. For eligibility and next steps, see Depo-Provera lawsuit information and Depo-Provera brain tumor lawsuit.

According to WHO classification data, meningiomas are typically graded WHO Grade I tumors, yet surgical resection rates climb when tumors enlarge or compress critical structures.

Top Tier Legal, LLC is not a law firm and does not provide legal advice. This content is for informational purposes only. Submitting information does not create an attorney-client relationship. If you qualify, Top Tier Legal, LLC may connect you with an independent law firm. Past results do not guarantee future outcomes.

Women who developed meningiomas after Depo-Provera injections may qualify for compensation.

No-cost evaluation for women who used Depo-Provera and developed a brain tumor.

Check your Depo-Provera eligibility